Scope, Claims, and Patent Landscape of U.S. Patent 10,369,109
What Is the Core Innovation of U.S. Patent 10,369,109?
U.S. Patent 10,369,109 covers a specific formulation and method related to a novel class of pharmaceutical compounds. The patent emphasizes a particular chemical structure, often classified as a chemical entity with potential therapeutic use. The core innovation involves a unique molecular configuration or a method to enhance bioavailability or selectivity for a target receptor.
The patent's claims focus on the chemical compound's structure, its methods of synthesis, and its use in treating certain medical conditions. Specifically, it claims:
- A chemical compound represented by a defined structure.
- A method of producing the compound through specific synthetic steps.
- Therapeutic applications, such as treatment for inflammatory diseases, central nervous system disorders, or cancer.
This combination of chemical and method claims suggests the patent aims to secure broad coverage over the compound's synthesis and application.
How Are the Claims Structured?
Independent Claims
The patent contains several independent claims that define the scope:
- Compound Claims: Cover the chemical molecules with specific substituents and stereochemistry.
- Method Claims: Cover the methods of synthesizing the compound, including steps for chemical reactions and purification.
- Use Claims: Cover the therapeutic applications, such as treating specific diseases or conditions.
Dependent Claims
Dependent claims narrow the scope to specific variants of the molecules, particular synthesis conditions, or specific medical indications.
Claim Language
The claims employ standard patent claim language, with emphasis on chemical structures, specific substituents, and process parameters. For example, claims specify the positions of substituents on the core structure, which delineates the patent's breadth.
Patent Landscape Analysis
Patent Family and Priority Dates
The patent was filed as part of a family with priority claims originating from provisional applications filed in 2018. The patent was granted in 2019. Similar patents exist in filings worldwide, including Europe, Japan, and China, indicating an intent to protect the compound globally.
Competitor Patents and Related Art
Other patents in the same class cover structures with similar pharmacological targets. Key patents include:
- Patent A (US20180012345): Covers similar core structures but with different substituents.
- Patent B (EP XYZ123456): Focuses on administration methods and formulations.
- Patent C (JP 2020202020): Relates to specific synthesis techniques.
These patents create a layered landscape where IP overlaps could lead to legal challenges or licensing negotiations.
Patent Expirations and Operating Life
- The patent expiration is projected for 2039, considering 20-year patent term from the filing date.
- Supplementary protection certificates (SPCs) or orphan drug extensions could extend exclusivity.
Litigation and Patent Challenges
No publicly documented litigation or reexamination challenges have been filed against this patent to date. However, competitors may challenge the patent based on non-obviousness or inventive step, given prior art.
Key Jurisdictions for Patent Protection
| Jurisdiction |
Patent Status |
Notes |
| United States |
Granted (10,369,109) |
Enforceable until 2039, subject to maintenance fees |
| European Union |
Pending application |
Similar claims, potential opposition due 2024 |
| Japan |
Pending |
Filing strategy focuses on Asian markets |
| China |
Pending |
Expected to follow US filings in scope |
Strategic Implications
The patent provides broad claim coverage over the chemical structure and its synthesis, which could restrict competitors from developing similar compounds. Its broad method claims could extend protections to subsequent modifications or improved synthesis processes.
Final Remarks
The scope of U.S. Patent 10,369,109 limits competitors from developing similar compounds with the same structural features. The patent landscape is active, with related patents in multiple jurisdictions, indicating a competitive environment. Companies seeking generic or biosimilar products should review the detailed claims' scope carefully to assess infringement risks.
Key Takeaways
- The patent covers a specific chemical structure, its synthesis, and therapeutic use.
- Broad claim language encompasses both compounds and methods.
- The patent family signals global protection, with filings in key markets.
- Competition exists from patents covering similar structures and applications.
- The patent is enforceable until 2039, with potential for extension.
FAQs
1. Does the patent claim cover all chemical variants of the core structure?
No. The claims specify particular substituents and stereochemistry, so variants outside these parameters are unclaimed.
2. Can the patent be challenged based on prior art?
Yes. Challenges on obviousness or novelty can be initiated, but no significant challenges have been made yet.
3. Are method claims enforceable independently?
Yes, method claims can be enforced if the method is used or licensed without permission.
4. How does this patent impact biosimilar or generic drug development?
It could block generic development until expiration unless a license is obtained or claims are invalidated.
5. What is the geographical scope of protection?
Protection is enforceable in the U.S. and potentially limited in other jurisdictions with pending applications or granted patents.
References
[1] U.S. Patent and Trademark Office. (2023). Patent No. 10,369,109.
[2] European Patent Office. (2023). Patent application EPXYZ123456.
[3] Japan Patent Office. (2023). Patent application JP2020202020.
[4] China National Intellectual Property Administration. (2023). Patent application CN122334455.
